Vera Therapeutics Inc
NASDAQ:VERA

Watchlist Manager
Vera Therapeutics Inc Logo
Vera Therapeutics Inc
NASDAQ:VERA
Watchlist
Price: 52.25 USD -2.48% Market Closed
Market Cap: 3.3B USD

Intrinsic Value

The intrinsic value of one VERA stock under the Base Case scenario is 3.16 USD. Compared to the current market price of 52.25 USD, Vera Therapeutics Inc is Overvalued by 94%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VERA Intrinsic Value
3.16 USD
Overvaluation 94%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Vera Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about VERA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is VERA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Vera Therapeutics Inc.

Explain Valuation
Compare VERA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VERA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vera Therapeutics Inc

Current Assets 511.3m
Cash & Short-Term Investments 497.4m
Receivables 3.4m
Other Current Assets 10.6m
Non-Current Assets 6.2m
PP&E 3.2m
Other Non-Current Assets 3m
Current Liabilities 41.9m
Accounts Payable 18m
Accrued Liabilities 23.9m
Non-Current Liabilities 76.7m
Long-Term Debt 74.6m
Other Non-Current Liabilities 2.1m
Efficiency

Free Cash Flow Analysis
Vera Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vera Therapeutics Inc

Revenue
0 USD
Operating Expenses
-270.2m USD
Operating Income
-270.2m USD
Other Expenses
18.2m USD
Net Income
-251.9m USD
Fundamental Scores

VERA Profitability Score
Profitability Due Diligence

Vera Therapeutics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
23/100
Profitability
Score

Vera Therapeutics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

VERA Solvency Score
Solvency Due Diligence

Vera Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
74/100
Solvency
Score

Vera Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VERA Price Targets Summary
Vera Therapeutics Inc

Wall Street analysts forecast VERA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VERA is 75.24 USD with a low forecast of 33.33 USD and a high forecast of 105 USD.

Lowest
Price Target
33.33 USD
36% Downside
Average
Price Target
75.24 USD
44% Upside
Highest
Price Target
105 USD
101% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VERA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VERA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VERA stock?

The intrinsic value of one VERA stock under the Base Case scenario is 3.16 USD.

Is VERA stock undervalued or overvalued?

Compared to the current market price of 52.25 USD, Vera Therapeutics Inc is Overvalued by 94%.

Back to Top